Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cellsDaniel A. Lichtenstein, Nirali N. Shah, Philip Homan et al.|Blood|2021Cited by 194
Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapyBrittany M. Lee, Adam J. Lamble, Corinne Summers et al.|Blood Advances|2023Cited by 16
<i>CRLF2</i> -rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapySara Silbert, Nirali N. Shah, Samantha Scanlon et al.|Journal for ImmunoTherapy of Cancer|2024Cited by 8
Monocytic Differentiation in B-Lymphoblastic Leukemia with <i>CRLF2</i> rearrangement at Diagnosis: Implications for Pathogenesis and Post-Therapeutic Lineage SwitchAlexandra E. Kovach, Brent L. Wood, Sara Silbert et al.|Blood|2024Cited by 2
ContributorsSteven H. Abman, Dan Doherty, Karel Allegaert et al.|Avery's Diseases of the Newborn|2018Cited by 0